by Todd Bishop on Aug 27, 2026 at 9:16 am August 27, 2026 at 9:16 am
An AI system built by Seattle’s Allen Institute for AI (Ai2) has found evidence that a common form of breast cancer, long thought to be a poor candidate for immunotherapy, might actually respond to it.
The finding, produced by Ai2’s AutoDiscovery system, has led to an expanded partnership with the Paul G. Allen Research Center at Providence Swedish Cancer Institute, which is now deploying the AI system on its own patient data to look for similar scenarios across other types of disease.
The announcement Thursday illustrates the broader potential for AI to uncover findings that…
Read the full article at GEEKWIRE.COM


